The company’s executive team is scheduled to host the call at 5:00 p.m. U.S. EDT. Investors and analysts can access the discussion via the firm's investor relations portal, where supplementary materials will be posted shortly before the event begins. A replay of the proceedings will remain available on the same digital platform for those unable to attend the live session.
Bausch Health Sets July 29 Date for Second Quarter Earnings
Bausch Health Companies Inc. will disclose its financial performance for the second quarter of 2026 after the markets close on Wednesday, July 29. The Laval-based pharmaceutical firm plans to follow the release with a live conference call and webcast to detail its business trajectory and quarterly outcomes.
Bausch Health maintains a diverse portfolio spanning gastroenterology, neuroscience, and dermatology, alongside its controlling interest in Bausch + Lomb. This upcoming update serves as a key indicator for stakeholders tracking the company's broader efforts to integrate its healthcare operations globally.
Comments (0)
No comments yet. Be the first!